A detailed history of Aqr Capital Management LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 64,791 shares of ANNX stock, worth $338,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,791
Previous 279,463 76.82%
Holding current value
$338,856
Previous $1.37 Million 72.02%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.49 - $7.2 $963,877 - $1.55 Million
-214,672 Reduced 76.82%
64,791 $383,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $1.16 Million - $1.82 Million
268,085 Added 2356.17%
279,463 $1.37 Million
Q1 2024

May 15, 2024

BUY
$4.03 - $7.81 $45,853 - $88,862
11,378 New
11,378 $81,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $4.06 $56,674 - $109,051
-26,860 Reduced 45.62%
32,021 $121,000
Q1 2022

May 16, 2022

BUY
$2.73 - $11.94 $160,745 - $703,039
58,881 New
58,881 $161,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.